알츠하이머병 알츠하이머병 관련 인터뷰, 자료 및 비디오 Alzheimer's Disease 16 Aug, 2023 Read Time: 4 mins Satellite symposium Article [EAN Insight] 신경염증 - 알츠하이머병에서 왜 중요할까? Currently there are few options for the treatment of Alzheimer’s disease (AD), with... Mental Health 16 Aug, 2023 Read Time: 7 mins Article [EAN Insight] 제9차 유럽신경학회 학술대회 하이라이트 From 1st to 4th July 2023, nearly 8,000 neurologists from 114 countries gathered both virtually and... Alzheimer's Disease 24 Jul, 2023 Read Time: 8 mins Article 알츠하이머병의 이질성 조사를 위한 뇌영상 기술 In this symposium, titled ‘Neuropsychological assessment for different populations: from cultural... Alzheimer's Disease 17 May, 2023 Read Time: 8 mins Article 알츠하이머병 및 기타 신경변성 질환에서의 타우 단백질의 신경 병리학 In this symposium titled ‘Human Neuropathology: Tau, a key protein in the human brain,’ Dr Corey T.... Alzheimer's Disease 24 Apr, 2023 Read Time: 4 mins Congress highlights Article [EAN Insight] 경도인지장애 및 생체표지자에 기초한 치매 예측 Mild cognitive impairment alone is not an indicator of Alzheimer’s disease and cannot be used to... Alzheimer's Disease 03 Apr, 2023 Read Time: 6 mins Satellite symposium Article [EAN Insight] 알츠하이머병의 임상 결과 평가 Clinical outcomes are vital to assess a person with Alzheimer’s disease (AD) and track their... Alzheimer's Disease 25 Jan, 2023 Read Time: 3 mins Congress highlights Article [AD/PD Insight] 알츠하이머병의 3가지 주요 유형 Alzheimer’s disease is not part of normal aging. It is a brain disorder and not all people with... Alzheimer's Disease 29 Sep, 2022 Read Time: 4 mins Congress highlights 치매 발병에 있어 개선 가능한 위험 인자의 대륙별 분석 Steady growth is predicted in cases of dementia over the next 40 years – both in high-, middle- and... Alzheimer's Disease 25 Aug, 2022 Read Time: 3 mins Congress highlights Article 타우 표적화 – 알츠하이머병의 효과적인 치료법에 대한 관심 Several new and highly promising therapeutics for the management and possible prevention of... Alzheimer's Disease 28 Jul, 2022 Read Time: 4 mins 최신 리뷰 무증상 알츠하이머병에서의 아밀로이드 베타의 역할 및 ApoE 유전자에 대한 민족적 감수성 Understanding the pre-symptomatic changes underlying Alzheimer’s disease and other dementias is of... Alzheimer's Disease 10 Jun, 2022 Read Time: 3 mins Congress highlights 알츠하이머 및 치매 환자의 뇌에서는 어떤 일이 벌어질까요? The brains of people with Alzheimer’s disease contain abnormal proteins—amyloid-beta and... Alzheimer's Disease 29 Apr, 2022 Read Time: 3 mins Satellite symposium 알츠하이머 환자의 여정 The Alzheimer’s disease patient journey starts with detection and progresses through to diagnosis,... Alzheimer's Disease 24 Mar, 2022 Read Time: 3 mins Satellite symposium 뇌 건강을 손상시키고 알츠하이머병의 위험을 증가시키는 요인 Knowing the factors that increase the risk of Alzheimer’s disease can help healthcare providers... Alzheimer's Disease 24 Feb, 2022 Read Time: 3 mins Congress highlights 알츠하이머병의 위험이 있는 사람들을 식별하기 위한, 보다 접근 가능하고 가격이 적당한 새로운 기술 In specialist clinics, cerebrospinal fluid biomarkers for Abeta1-42, Abeta1-40, tTau, and pTau or... Alzheimer's Disease 10 Feb, 2022 Read Time: 3 mins Congress highlights 혈장 P-타우(P-tau)는 진단의 정확성과 인지 저하 예측을 약속한다 Extraordinary advances in plasma tau biomarkers, and especially in P-tau217, offer to aid diagnostic... Alzheimer's Disease 16 Dec, 2021 Read Time: 3 mins Satellite symposium 조기 진단 및 예방의 어려움과 기회 Mixed dementia etiologies, and neuropsychiatric symptoms that overlap cognitive deficits illustrate... Alzheimer's Disease 12 Aug, 2021 Read Time: 3 mins Satellite symposium 아밀로이드 PET 이미징 기술이 진단 및 치료에 가져오는 변화 Access to amyloid PET changes the diagnosis and care of many patients in whom the diagnosis of... Alzheimer's Disease, Parkinson's Disease 15 Feb, 2021 Read Time: 3 mins Article Winter poses climatic and cultural challenges Seasonal fluctuations in the symptoms of Alzheimer’s and Parkinson’s Diseases may increase care needs... Alzheimer's Disease 19 Oct, 2020 Read Time: 3 mins Congress highlights 마이크로바이옴 조절: 진행 중인 혁명인가? Altering the intestinal flora can influence host immunity, neuro-inflammation, and the deposition of... Alzheimer's Disease 25 Sep, 2020 Read Time: 3 mins Congress highlights AD진단의 바이오마커 - 아밀로이드 베타와 타우 Novel tracers for PET imaging and the increasing range of CSF and plasma assays for amyloid-β and tau... Alzheimer's Disease 28 Aug, 2020 Read Time: 3 mins Congress highlights 알츠하이머병에 가장 취약한 인구 집단과 그 이유 Populations most vulnerable to Alzheimer’s disease (AD) need to be better represented in AD research... Alzheimer's Disease 21 Aug, 2020 Read Time: 3 mins Congress highlights 어떤 타우 바이오마커가 알츠하이머병 관련 정보를 가장 많이 담고 있는가? Aggregates of hyperphosphorylated and C-terminally truncated microtubule-associated tau protein are a... Alzheimer's Disease, Parkinson's Disease 17 Jul, 2020 Read Time: 5 mins Congress highlights 미가공 데이터를 실질적 지식으로 전환하는 머신러닝 We are in the age of big data. The number of biomedical variables that can be measured has exploded... Alzheimer's Disease 26 Jun, 2020 Read Time: 3 mins Congress highlights 이미징 기술을 통한 치매 진단과 병기 분류의 진보 Tau-PET imaging in the clinic is on the horizon and would complement amyloid-PET and structural and... Alzheimer's Disease 19 Jun, 2020 Read Time: 2 mins Congress highlights 바이오마커 상담에 대한 지침 마련의 필요성 Clinicians value biomarkers when assessing mild cognitive impairment but are less certain about how... Alzheimer's Disease 08 May, 2020 Read Time: 2 mins Congress highlights 역동적 알츠하이머병 파이프라인의 다양한 핵심 표적 Far from running dry, the pipeline is well provided with agents in development for Alzheimer’s... Alzheimer's Disease 14 Feb, 2020 Read Time: 3 mins Congress highlights 전임상 알츠하이머병을 발견할 수 있는 빠르고 간편한 두 가지 기술 Alzheimer’s disease (AD) is preceded by an asymptomatic (preclinical) phase that may last decades.... Alzheimer's Disease 07 Feb, 2020 Read Time: 1 min Article [EBM] 우울증과 기억력의 관계: 치매 vs. 가성치매 우울증과 인지기능 이상 우울증은 정서 조절의 이상이 주 증상인 질환이지만, 많은 우울증 환자들은 주의집중력의 저하, 판단의 어려움, 기억력 저하 같은 인지기능... Alzheimer's Disease 06 Dec, 2019 Read Time: 3 mins Congress highlights 알츠하이머 치매 관련 agitation의 검사 및 관리 Agitation is common among patients with Alzheimer’s disease (AD) and results in a range of behavioral... Alzheimer's Disease 27 Sep, 2019 Read Time: 3 mins Congress highlights 신경퇴행성 질환에서 별세포가 뉴런을 손상시키는 이유는 무엇인가? - 알츠하이머병 발병기전에 관한 새로운 통찰 Why do star cells damage neurons in neurodegenerative diseases, including Alzheimer’s disease... Alzheimer's Disease 20 Sep, 2019 Read Time: 3 mins Congress highlights 혈장 Aβ와 뇌 Aβ 연관성이 주목받고 있습니다: 이는 알츠하이머병의 발병에 중요한 역할을 할까요? Reliable plasma amyloid-β (Aβ) measurement is now possible using new highly sensitive techniques, and... Alzheimer's Disease 04 Sep, 2019 Read Time: 3 mins Congress highlights 양질의 수면을 위한 중재 치료가 알츠하이머병 예방에 도움이 되는가? Sleep disturbance appears to be a risk factor for and an early manifestation of Alzheimer’s disease... Alzheimer's Disease 30 Aug, 2019 Read Time: 3 mins Congress highlights 알츠하이머병 조기 개입을 위한 타우 표적 연구 The microtubule-associated protein tau is a major component of the neurofibrillary tangles (NFT) of... Alzheimer's Disease 22 Aug, 2019 Read Time: 4 mins Congress highlights 알츠하이머병 환자를 위한 완전한 해결책이 지평선 위에 있을지도 모릅니다 New treatments and improved diagnostic and staging tools will allow for a complete solution for... 우울증, Alzheimer's Disease 24 Jun, 2019 Read Time: 4 mins Congress highlights 비만과 운동을 통해 발견한 우울증과 조현병의 새로운 잠재적 표적 Weight loss and exercise increase benefit for mental health, but are difficult to achieve. The... Alzheimer's Disease 31 May, 2019 Read Time: 3 mins Congress highlights 알츠하이머병에 대한 면역 반응 촉진: 증강제(adjuvants) 활용, 마이크로바이옴(microbiome) 조절, 소교세포 활력 회복(microglial rejuvenation) Modulating central and peripheral innate immunity has potential in Alzheimer’s Disease. Following... Alzheimer's Disease 20 May, 2019 Read Time: 4 mins Congress highlights 알츠하이머병 조기진단을 위한 준비 When disease-modifying therapy becomes available, screening for Alzheimer’s and its subsequent... Alzheimer's Disease 26 Apr, 2019 Read Time: 4 mins Congress highlights 알츠하이머 임상시험으로 알게 된 사실들 The phase 3 trials in Alzheimer’s Disease teach us how to improve selection of patients so that we... Alzheimer's Disease 05 Apr, 2019 Read Time: 3 mins Article 알츠하이머병 예방은 현실적으로 가능한 목표인가요? A prospective cohort study is under way in high-risk subjects, with the aim of validating potential... Alzheimer's Disease 07 Dec, 2018 Read Time: 1 min Article [EBM] 치매 치료제 개발을 향한 기대와 희망 치매 걱정, 관심, 새로운 뉴스 치매는 누구나 걸릴 수 있습니다. 우리 신체가 늙어가며 약해지듯 우리 뇌도 시간이 지날수록 기능이 떨어지기 때문이지요. 평균수명이 짧을 때에야 치매... Alzheimer's Disease 05 Oct, 2018 Read Time: 3 mins Congress highlights [AAIC Insight] 알츠하이머병의 신경망 기능 장애 기전 이해하기 Amyloid precursor protein/amyloid-beta and tau appear to act together to cause deficits in synaptic... Alzheimer's Disease 21 Sep, 2018 Read Time: 4 mins Congress highlights [AAIC Insight] 치매 환자를 위한 인간 중심 케어, 얼마나 이루어졌는가? Interest in psychosocial research in people living with dementia and their caregivers is growing.... Alzheimer's Disease 17 Sep, 2018 Read Time: 5 mins Congress highlights [AAIC Insight] 알츠하이머병과 빅데이터 활용 In this symposium, recent trends in data analysis and study design were discussed alongside... Alzheimer's Disease 10 Sep, 2018 Read Time: 3 mins Congress highlights [AAIC Insight] 노화, 아밀로이드, 그리고 알츠하이머병 Amyloid-beta (Aβ) burden in cognitively normal older adults increases with age and appears to be... Alzheimer's Disease 27 Jul, 2018 Read Time: 2 mins Congress highlights 아포지단백E 유전자검사 현명하게 선택하기 Most Popular
